CYP2J2 and breast cancer: Expression of CYP2C8/9 and CYP2J2, and/or high level of 14,15-EET detected in patients were found to be positively correlated with aggressiveness of human BC [29], or that might be involved in breast cancer cell epithelial-mesenchymal transition and cisplatin resistance [30].